Strengthening and expanding capacities in clinical trials: advancing pandemic prevention, preparedness and response in Africa

Enhancing the clinical trial capabilities within Africa is essential to augment the continent’s pandemic prevention, preparedness and response efforts. Here, we describe the critical challenges of clinical trials in Africa and draw upon the lessons learnt from the Consortium for COVID-19 Vaccine Clinical Trials (CONCVACT) experience, such as the importance of regional collaboration, capacity building and establishing standardized protocols.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2024-10-07
DOI
https://doi.org/10.1038/s41467-024-53126-3
Citations
29
Primary Topic
Viral Infections and Outbreaks Research
Type
article
Field-Weighted Citation Impact
11.28

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Strengthening and expanding capacities in clinical trials: advancing pandemic prevention, preparedness and response in Africa

Michael Makanga, Nebiyu Dereje, Morẹ́nikẹ́ Oluwátóyìn Foláyan, Jean Bisimwa Nachega et al.
29 citations
Nature Communications
Viral Infections and Outbreaks Research
11.28
article

Strengthening and expanding capacities in clinical trials: advancing pandemic prevention, preparedness and response in Africa

Michael Makanga, Nebiyu Dereje, Morẹ́nikẹ́ Oluwátóyìn Foláyan, Jean Bisimwa Nachega, Yap Boum, Elvis Temfack, Nicaise Ndembi, Glaudina Loots, Tajudeen Raji, Samba O. Sow, Francine Ntoumi, Trevor A. Crowell, Joseph Fokam, Salim S. Abdool Karim, Souleymane Mboup, Ngashi Ngongo, John Nkengasong, Tadesse T. Mekonen, A. Krüger
article en
29 citations

Abstract

Enhancing the clinical trial capabilities within Africa is essential to augment the continent’s pandemic prevention, preparedness and response efforts. Here, we describe the critical challenges of clinical trials in Africa and draw upon the lessons learnt from the Consortium for COVID-19 Vaccine Clinical Trials (CONCVACT) experience, such as the importance of regional collaboration, capacity building and establishing standardized protocols.

Nature CommunicationsVol. 15(1)
Henry M. Jackson Foundation (US), Stellenbosch University (ZA), Centre for the AIDS Programme of Research in South Africa (ZA), Department of Science,Technology and Innovation (ZA), Centre Pour le Développement des Vaccins-Mali (ML), Centre International De Reference Chantal Biya (CM), Institut Pasteur de Bangui (CF), Fondation Congolaise Pour La Recherche Médicale (CG), Africa Centres for Disease Control and Prevention (ET), President's Emergency Plan for AIDS Relief (US), Institute of Health Research, Epidemiological Surveillance and Training (SN), Joint Research Center (BE), Obafemi Awolowo University (NG), Columbia University (US), University of Tübingen (DE)
Henry M. Jackson Foundation, Skoll Foundation, Eberhard Karls Universität Tübingen, Universiteit Stellenbosch, Centers for Disease Control and Prevention, Faculty of Medicine and Health, University of Sydney, National Institute of Allergy and Infectious Diseases, Mailman School of Public Health, Columbia University, European and Developing Countries Clinical Trials Partnership
Openalex Percentile: Top 1%
Viral Infections and Outbreaks Research
11.28
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.